Company / Free Cash Flow per Share
BioNexus Gene Lab Corp Free Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.04
FY2025
5-year range
-$1.04 / $0.00
FY2021-FY2025
Trend
-694.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed -695% YoY in FY2025, a notable deviation from the 6-year average annual change of +688%.
Based on SEC 10-K filings.
-1.04 in FY2025.
Declined from $-0.14 to $-1.04 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 694.8% year-over-year.
- Peak free cash flow per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.04 | -694.8% |
| FY2024 | -$0.13 | +3.6% |
| FY2023 | -$0.14 | -4325.8% |
| FY2022 | $0.00 | +9098.6% |
| FY2021 | $0.00 | -97.3% |
| FY2020 | $0.00 | +141.4% |
| FY2019 | -$0.00 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026